Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
China Regenerative Medicine International Limited (HK:8158)
:8158
8158 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$0.09 - HK$1.27
Previous CloseN/A
Volume500.00
Average Volume (3M)20.81K
Market Cap
HK$80.63M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.41
Next Earnings
Mar 26, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding304,252,470
10 Day Avg. Volume18,548
30 Day Avg. Volume20,810
Standard Deviation0.38
R-Squared0.00087
Alpha0.00307
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
8158 FAQ
What was China Regenerative Medicine International Limited’s price range in the past 12 months?
China Regenerative Medicine International Limited lowest stock price was HK$0.09 and its highest was HK$1.27 in the past 12 months.
What is China Regenerative Medicine International Limited’s market cap?
China Regenerative Medicine International Limited’s market cap is HK$80.63M.
When is China Regenerative Medicine International Limited’s upcoming earnings report date?
China Regenerative Medicine International Limited’s upcoming earnings report date is Mar 26, 2025 which is in 33 days.
How were China Regenerative Medicine International Limited’s earnings last quarter?
Currently, no data Available
Is China Regenerative Medicine International Limited overvalued?
According to Wall Street analysts China Regenerative Medicine International Limited’s price is currently Overvalued.
Does China Regenerative Medicine International Limited pay dividends?
China Regenerative Medicine International Limited does not currently pay dividends.
What is China Regenerative Medicine International Limited’s EPS estimate?
China Regenerative Medicine International Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China Regenerative Medicine International Limited have?
China Regenerative Medicine International Limited has 304,252,470 shares outstanding.
What happened to China Regenerative Medicine International Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of China Regenerative Medicine International Limited?
Currently, no hedge funds are holding shares in HK:8158
---
Company Description
China Regenerative Medicine International Limited
China Regenerative Medicine International Ltd is a biotechnology company that researches and commercializes regenerative medicine products in China. CRMI focuses on five major business segments: Dermatology, cosmetic products and others, Cell and healthcare products and services, Ophthalmology products, Stomatology products and others, and Medical equipment. Geographically, the People's Republic of China accounts for majority revenue. The vast majority of the company's revenue is derived from its Medical equipment segment.
---
Technical Analysis
Ping An Insurance Company of China
―
Sino Biopharmaceutical
―
China Medical System Holdings
―
Livzon Pharmaceutical Group
―
Shandong Weigao Group Medical Polymer Co
―
---